Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
36.16%
↑ 176% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-47.63%
Historical baseline
PeriodValue
202436.16%
2023-31.78%
2022-4.96%
2021-82.29%
2020-153.57%
2019-96.97%
20180.00%